Key facts
- Iroquois Capital Management, LLC filed SCHEDULE 13G/A for Petros Pharmaceuticals, Inc. Common Stock, $0.0001 par value (PTPI).
- Disclosed ownership: 10%.
- Date of event: 31 Mar 2025.
Iroquois Capital Management, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Petros Pharmaceuticals, Inc. Common Stock, $0.0001 par value (PTPI)
- Filing Manager
- Iroquois Capital Management, LLC
- Reporting Manager
- Iroquois Capital Management, LLC
- Symbol
- PTPI
- Shares outstanding
- 59,458,999 shares
- Disclosed Ownership
- 5,939,954 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2025, 10:15:32 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 26 Feb 2025
- SEC
- View on sec.gov
Key filing fact
Iroquois Capital Management, LLC disclosed 10% ownership in Petros Pharmaceuticals, Inc. Common Stock, $0.0001 par value (PTPI) on 31 Mar 2025.
Change
- Previous schedule filing date: 26 Feb 2025.
- Current filing was accepted on 15 May 2025, 10:15.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Iroquois Capital Management, LLC | 10% | 5,939,954 | 0 | 5,939,954 | /s/ Richard Abbe | Richard Abbe | |
| Richard Abbe | 10% | 5,939,954 | 5,939,954 | 5,939,954 | /s/ Richard Abbe | Richard Abbe | |
| Kimberly Page | 10% | 5,939,954 | 0 | 5,939,954 | /s/ Kimberly Page | Kimberly Page |
CIK / CUSIP context first